2018 Archives - Page 2 of 2 -

Becker’s Hospital Review: Tumor microenvironment is a powerful companion diagnostic for cancer immunotherapy applications

March 15, 2018

Becker’s Hospital Review, 2018 Currently approved checkpoint inhibitors are antibodies that block the function of three key proteins expressed on the surface of T cells: CTLA-4, PD-1 and PD-L1. Under normal conditions, these proteins function as brakes to prevent immune-related toxicity from arising because of persistent T cell activity. Cancer hijacks this essential function

Noninvasive prenatal testing (NIPT) detects variant of Turner syndrome not detectable by fluorescent in situ hybridization

Molecular alterations associated with chronic exposure to cigarette smoke and chewing tobacco in normal oral keratinocytes

Becker’s Hospital Review: Tumor microenvironment is a powerful companion diagnostic for cancer immunotherapy applications

Clinical, Immunological, and Molecular Findings in Five Patients with Major Histocompatibility Complex Class II Deficiency from India

Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India

The complete mitochondrial genome of Indian cattle (Bos indicus)

Single Nucleotide Polymorphism-Based Noninvasive Prenatal Testing: Experience in India

Ancient Human Migrations to and through Jammu Kashmir- India were not of Males Exclusively

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer